Q&A with Jaime Punishill, CMO at Lionbridge

MEDIA 7 | August 26, 2019

Jaime Punishill, CMO at Lionbridge is an innovative marketing, channel, and product executive with a proven track record for finding blue ocean strategies and delivering scalable business operations.

Jaime is also an expert in operationalizing design thinking, translating new concepts and trends into workable business plans and operations, and delivering pragmatic innovation within a large enterprise.

MEDIA 7: Could you tell us about your role and journey into marketing?
JAIME PUNISHILL:
As Chief Marketing Officer for Lionbridge, I oversee brand, demand gen, corporate communications, marketing, and customer research. Interestingly enough, I’m not a classic marketer by training. I have spent most of my career on the product side and in digital transformation. I’ve been doing that since the mid-1990s. At some point, it became clear that marketing was the next area that universal digital transformation was going to overtake, and areas like user experience and many other digital functions that had been done separately were going to move under the remit of marketing. I slowly moved into the marketing universe and helped with big digital transformation in my previous company. That led me to take on all our brand, advertising, and integrated marketing. In that way, I ended up with a more traditional marketing role, and that led me to Lionbridge.

M7: As a CMO, what are the biggest challenges you face?
JP:
One of the biggest challenges is the unbelievable explosion in the martech space. I get over 300-400 emails and dozens of phone calls every day from different vendors who are trying to push different tools to help optimize the new digital experience. Keeping track of the rapid pace of evolution and trying to integrate all those tools is single-handedly probably one of the biggest challenges for CMOs. It swallows historical challenges, like getting the company to buy into a new understanding of the digital universe, or getting people to appreciate customer research and customer feedback.
These are always challenges, but they are all lower in scale now than just sheer digital transformation and the volume of tools and resources that accompany that transformation. There’s so much noise, and it’s really hard to tell what’s real and what’s not real.


"Keeping track of the rapid pace of evolution and trying to integrate all those tools is single-handedly probably one of the biggest challenges for CMOs."

M7: What was the most successful marketing campaign you have ever worked on? What made it so successful?
JP:
In my previous organization, we led a re-brand of the company in its first-ever national advertising campaign. That meant we weren’t constrained by existing rules and assumptions about how things had to be done, so we were able to quite creatively and innovatively harness several digital channels in a way that many of our competitors hadn’t. In terms of revenue or asset flows, new customers, traffic to the website and just about every other metric, it was a tremendous lift. That’s probably the single-most effective marketing campaign I’ve worked on, and it was completely comprehensive. It had a brand component, a communications component, a community component. It had very specific direct targeting and campaigns along with a goal of raising basic awareness. We were targeting by social media profile and audience. I think it was successful largely because it was multi-faceted and end-to-end.

M7: At Lionbridge, how do you see AI evolving with digital media?
JP:
For AI, we are still really in a hype-cycle. There is absolutely no doubt that AI and everything that falls under its purview will have a profound impact on the scale, data, and decisions we are able to process as marketers. The number of simulations and tests we will be able to run to optimize a campaign or project pre-launch, plus the ability for us to pivot real-time and use new insights, will be absolutely profound. But I think we are still very early in the journey. There’s more hype than substance right now. I’m not skeptical about AI’s eventual impact at all. But right now, the tools are not mature, and we are not mature in our understanding of AI, even regarding some of the most impactful ways to use it. So, I’m super optimistic over a 3-5-7-year period. But, I’m very skeptical over a 6-12-24-months period.


"AI and everything that falls under its purview will have a profound impact on the scale, data, and decisions we are able to process as marketers."

M7: How does the acquisition of Gengo strengthen Lionbridge’s position in machine learning?
JP: We are one of the world leaders in AI training data services. The fuel that makes AI work effectively is incredibly high volumes of high-quality data. And the problem is, as we know, most organizations have not done a good job being stewards of their data. Their data exists in lots of places, their data is not clean, it’s not annotated or mapped, there’s no organizing taxonomy around its structure. CDPs are still relatively early for a lot of folks, and so the catch is that you have lots of data, but that data may be largely unusable. Sort of like, there is a lot of oil in the ground, but just because the oil is in the ground doesn’t mean you have gas that works in your car or in a plane. A lot has to happen to refine it, to get it ready. The same is true with data “fuel.”

The good news is that we are one of the world leaders in helping companies refine their data so it’s usable in training their AI systems. Identifying and collecting data, and giving that data meaning, for example, is it metadata or actual data, is that an important variable or not an important variable, etc., is an integral step in the machine learning process. We help companies collect data, organize it, give it meaning so it can best feed our customers’ AI platforms.

We do this by activating our one million-strong SmartCrowd. The Gengo platform really helps us create a scalable system that will allow more companies to be able to improve the quality of their AI training data and, in turn, the quality of their AI.

M7: How do you stay updated on the latest trends in marketing technology?
JP: 
I read a lot. I get a couple of hundred emails a day. Part of that is because I sign up for lots of different sources of information. I think you have to consume a tremendous amount of information right now to pull in all the weak signals. And I probably dedicate more of my days than I would normally to looking at new capabilities just to keep me informed and up-to-date. This allows me to get a sense of when I think something is at a point where we can use it and harness something early for a strategic advantage.


"Most organizations have not done a good job being stewards of their data. Their data exists in lots of places, their data is not clean, it’s not annotated or mapped, there’s no organizing taxonomy around its structure."

M7: What are the top 3 trends that you foresee for 2019 going into 2020?
JP:
We are going to hear more about AI. We will see more examples of it not working in the next 18 months than we will see examples of it working, but I think that’s a short-term phenomenon, and we will work out the issues.

I think there is absolutely no doubt that we are going to see an increase in the production and consumption of video and its import in the production cycle. People are consuming more and more videos, and even B2B buyers are much more heavily consuming videos as a way to absorb a lot of information in a pretty short period of time. In 2-3 minutes, you can convey a lot more, and frankly people can understand a lot more than if they spend 20 minutes reading a whitepaper or something of that nature.

And clearly, voice search is on a big rise. There are a couple of key reasons for that. If you think about the US workforce, half of it now only knows a universe where Google is the dominant information organizational paradigm. Pair that with the sheer explosion of speech applications and devices, whether in your home, in your car, or in your hand—today, every phone is speech-enabled. It’s clear that all the large players are investing a tremendous amount of effort into proving the quality of voice search, and an increasing number of users are speaking to a device or multiple devices to get information. That’s a real challenge for organizations and marketers, because the way people speak to their device and physically ask for information is not the same as how they type a query into a search engine. So, the whole way in which we optimize and organize for search results in a voice-search world is quite different than in a text-based or type-based universe.  

M7: What is your superpower?
JP:
I’m not really sure I have a superpower. But there’s something I think I do that seems to be more of a struggle for some others. I’m able to assemble a collection of weak signals to predict what is going to happen before it happens. I really believe all the information is there, but I seem to be able to use that information to make some good bets about what the future holds.

ABOUT LIONBRIDGE

Lionbridge partners with brands to break barriers and build bridges all over the world. For more than 20 years, we have helped companies connect with global customers by delivering marketing, testing and globalization services in more than 300 languages. Through our world-class platform, we orchestrate a network of 500,000 passionate experts in 5,000-plus cities, who partner with brands to create culturally rich experiences. Relentless in our love for linguistics, we use the best of human and machine intelligence to forge understanding that resonates with our customers’ customers. Based in Waltham, Mass., Lionbridge maintains solution centers in 27 countries. Learn more at www.lionbridge.com.

More C-Suite on deck

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Related News

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

HEALTHTECH SECURITY, HEALTHCARE ANALYTICS

Ribbon Health Expands Platform to Enable Access to Provider Appointment Booking, Eliminating Barriers to Care

prnewswire | March 24, 2023

Ribbon Health a leader in healthcare provider data technology and management, announced the launch of new platform features that will increase access to care through provider scheduling. Enabled by partnerships with leading booking marketplaces, these new platform capabilities empower patients to easily search for providers that both fit their needs and are accepting new patients, and book appointments with those providers for high-quality care across primary, specialty, urgent, or mental health. Ribbon's platform offers real-time availability data from health systems and direct partner integrations, giving care providers, navigators, and health plans a single source of truth to guide consumers to the right care. "Securing an appointment quickly" is the most important factor for having a positive healthcare experience, according to one-third of Americans surveyed in a recent report. Yet, there are a number of barriers inhibiting people from finding and booking high-quality care appointments when they need to most. Patients, providers, and care teams must navigate across multiple touchpoints, spend significant time and effort tracking down needed information, and contend with a growing physician shortage and a shrinking number of available therapists. All of these barriers lead to an average 26-day wait for an appointment in the best of circumstances, which could lead to worsening health, or patients opting out of care completely. These barriers to care will be removed with Ribbon's new capabilities such as insight into which providers are accepting new patients, provider appointment availability, and booking links. With partner integrations across leading booking platforms, patients can attend a virtual or in-person appointment in as little as 48 hours; this is compared to the national average of two to three weeks, if not months. Patients will have seamless access to high-quality mental health, primary, specialty, and urgent care at the fraction of the cost of out-of-network or emergency services. For the first time, patients, providers, and care teams can use one central platform to find the right care using Ribbon's comprehensive provider directory data, accepted insurances, cost, and quality metrics to understand whether a provider is available, and then book an appointment. "It shouldn't be harder to book care with a doctor than it is to book a flight or hotel," said Nate Maslak, Ribbon co-founder and CEO. "Unfortunately, that is still the case today. This launch is an important step in achieving our mission of accessible, affordable, and high-quality care for everyone. It will ensure patients can find the right doctor for their needs by allowing them to filter for availability and quickly book an appointment, rather than navigating through several websites or phone numbers each time and waiting weeks to months for care." Ribbon's enhanced capabilities will help healthcare organizations decrease the administrative burden for care teams looking to direct patients to in-network providers. By improving the provider search experience with data on whether a provider is accepting new patients and has availability, teams can increase referral confidence. "Making sure patients get to their referrals is critical for our business," said Jane Zhu, Director of Operations at Firefly Health, one of Ribbon's partners. "A big part of that is finding a provider who is not only a good clinical fit but is accepting new patients and available in the relevant time frame. Finding specialist availability is incredibly manual and time-consuming." Ribbon Health continues to launch new capabilities with the ultimate goal of transforming the experience of finding a provider, and paving the way to accessible, affordable, and high-quality care for all. Additional new releases include a Digital Care Network to expand a "provider search" beyond brick and mortar with leading, lower cost, virtual care options, as well as Price Transparency to allow patients to see detailed cost estimates alongside provider quality indicators before a care decision is made. About Ribbon Health Ribbon Health partners with innovators to transform how healthcare decisions are made. Ribbon's data platform fuels healthcare enterprises with actionable provider information, including insurance coverage, prices, and performance. With Ribbon, healthcare enterprises can empower people to make the most informed decisions about their care by finding trusted and affordable providers.

Read More

HEALTH TECHNOLOGY, MEDICAL DEVICES

Temple Health and Masimo Advance Patient Care Through Innovation Collaboration

Masimo | March 10, 2023

Masimo, a pioneer in technology and automation solutions for the healthcare industry, and Temple Health, a leading academic health system in Philadelphia, recently announced the formation of a strategic innovation collaboration. With a focus on advancing the forefront of telehealth and remote patient monitoring and automating high-quality care, the strategic partnership may involve using innovations such as the Radius VSMTM tetherless multimodal patient monitor, Masimo W1TM advanced health tracking watch, and various Masimo Hospital AutomationTM solutions. The collaboration aims to advance the organizations’ shared objectives of increasing care value, improving health, and transforming care delivery models. Masimo and Temple Health intend to collaborate in the following areas Raising awareness about health equity using their expertise and regional influence to improve access to quality care for Philadelphia residents. Demonstrating the future of healthcare by deploying next-generation therapies, devices, technologies, and systems to enhance patient-centered care across the care continuum, particularly in remote patient monitoring, automation, and telehealth. Joint research into healthcare technology best practices to minimize tech obsolesce in healthcare as telehealth and automation infrastructure become more sophisticated. Trial and refine the latest Masimo technologies by participating in the Temple Health ‘Collaboratory.’ Collaborative clinical research in inpatient, outpatient, and home settings, with technological innovation, cooperation and co-development. Key leaders’ engagement in clinical and technological exchanges aimed at pushing the frontiers of healthcare. Founder and CEO of Masimo, Joe Kiani, shared, “We are delighted to expand our relationship with Temple Health through this innovation collaboration and to work hand in hand to explore how Masimo’s monitoring, connectivity, and automation technologies, alongside Temple Health’s clinical expertise, can bring safe, easy-to-use, high-quality telehealth and remote patient monitoring services to their patients. We are committed to improving life, improving patient outcomes, and reducing the cost of care.” (Source – Business Wire) About Masimo Based in Irvine, California, Masimo is a global medical technology company specializing in developing and manufacturing breakthrough noninvasive patient monitoring technologies, including sensors and medical devices. For over 30 years, it has been dedicated to solving challenging problems in the medical industry. By offering clinically-proven and innovative products, and healthcare providers, the company is committed to making a measurable difference in the world by saving, prolonging, and enhancing the lives of people of every age and background. Its cutting-edge solutions offer real-time information to optimize clinical decision-making and improve patient safety.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

HEALTHTECH SECURITY, HEALTHCARE ANALYTICS

Ribbon Health Expands Platform to Enable Access to Provider Appointment Booking, Eliminating Barriers to Care

prnewswire | March 24, 2023

Ribbon Health a leader in healthcare provider data technology and management, announced the launch of new platform features that will increase access to care through provider scheduling. Enabled by partnerships with leading booking marketplaces, these new platform capabilities empower patients to easily search for providers that both fit their needs and are accepting new patients, and book appointments with those providers for high-quality care across primary, specialty, urgent, or mental health. Ribbon's platform offers real-time availability data from health systems and direct partner integrations, giving care providers, navigators, and health plans a single source of truth to guide consumers to the right care. "Securing an appointment quickly" is the most important factor for having a positive healthcare experience, according to one-third of Americans surveyed in a recent report. Yet, there are a number of barriers inhibiting people from finding and booking high-quality care appointments when they need to most. Patients, providers, and care teams must navigate across multiple touchpoints, spend significant time and effort tracking down needed information, and contend with a growing physician shortage and a shrinking number of available therapists. All of these barriers lead to an average 26-day wait for an appointment in the best of circumstances, which could lead to worsening health, or patients opting out of care completely. These barriers to care will be removed with Ribbon's new capabilities such as insight into which providers are accepting new patients, provider appointment availability, and booking links. With partner integrations across leading booking platforms, patients can attend a virtual or in-person appointment in as little as 48 hours; this is compared to the national average of two to three weeks, if not months. Patients will have seamless access to high-quality mental health, primary, specialty, and urgent care at the fraction of the cost of out-of-network or emergency services. For the first time, patients, providers, and care teams can use one central platform to find the right care using Ribbon's comprehensive provider directory data, accepted insurances, cost, and quality metrics to understand whether a provider is available, and then book an appointment. "It shouldn't be harder to book care with a doctor than it is to book a flight or hotel," said Nate Maslak, Ribbon co-founder and CEO. "Unfortunately, that is still the case today. This launch is an important step in achieving our mission of accessible, affordable, and high-quality care for everyone. It will ensure patients can find the right doctor for their needs by allowing them to filter for availability and quickly book an appointment, rather than navigating through several websites or phone numbers each time and waiting weeks to months for care." Ribbon's enhanced capabilities will help healthcare organizations decrease the administrative burden for care teams looking to direct patients to in-network providers. By improving the provider search experience with data on whether a provider is accepting new patients and has availability, teams can increase referral confidence. "Making sure patients get to their referrals is critical for our business," said Jane Zhu, Director of Operations at Firefly Health, one of Ribbon's partners. "A big part of that is finding a provider who is not only a good clinical fit but is accepting new patients and available in the relevant time frame. Finding specialist availability is incredibly manual and time-consuming." Ribbon Health continues to launch new capabilities with the ultimate goal of transforming the experience of finding a provider, and paving the way to accessible, affordable, and high-quality care for all. Additional new releases include a Digital Care Network to expand a "provider search" beyond brick and mortar with leading, lower cost, virtual care options, as well as Price Transparency to allow patients to see detailed cost estimates alongside provider quality indicators before a care decision is made. About Ribbon Health Ribbon Health partners with innovators to transform how healthcare decisions are made. Ribbon's data platform fuels healthcare enterprises with actionable provider information, including insurance coverage, prices, and performance. With Ribbon, healthcare enterprises can empower people to make the most informed decisions about their care by finding trusted and affordable providers.

Read More

HEALTH TECHNOLOGY, MEDICAL DEVICES

Temple Health and Masimo Advance Patient Care Through Innovation Collaboration

Masimo | March 10, 2023

Masimo, a pioneer in technology and automation solutions for the healthcare industry, and Temple Health, a leading academic health system in Philadelphia, recently announced the formation of a strategic innovation collaboration. With a focus on advancing the forefront of telehealth and remote patient monitoring and automating high-quality care, the strategic partnership may involve using innovations such as the Radius VSMTM tetherless multimodal patient monitor, Masimo W1TM advanced health tracking watch, and various Masimo Hospital AutomationTM solutions. The collaboration aims to advance the organizations’ shared objectives of increasing care value, improving health, and transforming care delivery models. Masimo and Temple Health intend to collaborate in the following areas Raising awareness about health equity using their expertise and regional influence to improve access to quality care for Philadelphia residents. Demonstrating the future of healthcare by deploying next-generation therapies, devices, technologies, and systems to enhance patient-centered care across the care continuum, particularly in remote patient monitoring, automation, and telehealth. Joint research into healthcare technology best practices to minimize tech obsolesce in healthcare as telehealth and automation infrastructure become more sophisticated. Trial and refine the latest Masimo technologies by participating in the Temple Health ‘Collaboratory.’ Collaborative clinical research in inpatient, outpatient, and home settings, with technological innovation, cooperation and co-development. Key leaders’ engagement in clinical and technological exchanges aimed at pushing the frontiers of healthcare. Founder and CEO of Masimo, Joe Kiani, shared, “We are delighted to expand our relationship with Temple Health through this innovation collaboration and to work hand in hand to explore how Masimo’s monitoring, connectivity, and automation technologies, alongside Temple Health’s clinical expertise, can bring safe, easy-to-use, high-quality telehealth and remote patient monitoring services to their patients. We are committed to improving life, improving patient outcomes, and reducing the cost of care.” (Source – Business Wire) About Masimo Based in Irvine, California, Masimo is a global medical technology company specializing in developing and manufacturing breakthrough noninvasive patient monitoring technologies, including sensors and medical devices. For over 30 years, it has been dedicated to solving challenging problems in the medical industry. By offering clinically-proven and innovative products, and healthcare providers, the company is committed to making a measurable difference in the world by saving, prolonging, and enhancing the lives of people of every age and background. Its cutting-edge solutions offer real-time information to optimize clinical decision-making and improve patient safety.

Read More

Spotlight

Lionbridge

Lionbridge

Lionbridge partners with brands to break barriers and build bridges all over the world. For more than 20 years, we have helped companies connect with global customers by delivering marketing, testing and globalization services in more than 300 languages. Through our world-class platform, we orchestr...

Events

Resources